Cuprina Holdings (Cayman) Limited Class A Ordinary Shares
- Market Cap (Float-Adj) (Float-adjusted market cap computed by the low-float screener — matches the screener row. May differ from the standard cap (price × all shares outstanding) reported elsewhere.)
- $7.4M
- Price
- $2.76
- % Change (Daily % change from the live per-ticker quote feed.)
- -2.13%
- Volume
- 5.4K
About
Cuprina Holdings (Cayman) Limited is a Singaporean biotechnology and biomedical enterprise, primarily dedicated to pioneering and bringing to market advanced solutions for the management of persistent wounds. The company produces and supplies its flagship MEDIFLY brand, which features medical-grade sterile blowfly larvae bio-dressing products designed to function as an effective biological debridement tool for chronic wounds. Beyond its core wound care business, Cuprina also extends its operations into the broader health and beauty market, where it provides a range of cosmeceutical items.
Quick stats
Shares outstanding2.7M
Computed float920.6K
Float / shares34.3%
Key info
SectorHealthcare
IndustryMedical - Instruments & Supplies
CIK (Central Index Key — the unique ID the SEC assigns to every filer. Use it to look up the company's filings on EDGAR.)0001995704
Websitehttps://www.cuprina.com.sg
AI Summary
AI-generated1/16
minorneutralother
Super Copper to Present at the Clean Energy & Metals Virtual Investor Conference on August 27th
Super Copper announced that Founder and CEO Zachary Dolesky will present at the Clean Energy & Metals Virtual Investor Conference on August 27, 2026.
The live presentation is scheduled for 2:30pm – 3:00pm ET and will be archived for later viewing.
Recent company highlights include the commencement of maiden drilling at the Cordillera Cobre Project and the identification of new kilometre-scale targets at the Castilla Project.